Back to Search
Start Over
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity.
- Source :
-
Hematological oncology [Hematol Oncol] 2020 Apr; Vol. 38 (2), pp. 204-206. Date of Electronic Publication: 2020 Jan 27. - Publication Year :
- 2020
- Subjects :
- Acute Kidney Injury chemically induced
Acute Kidney Injury enzymology
Acute Kidney Injury immunology
Aged
Autoantibodies blood
Bortezomib administration & dosage
Dexamethasone administration & dosage
Female
Humans
Multiple Myeloma pathology
Prognosis
Thalidomide administration & dosage
Urate Oxidase administration & dosage
Urate Oxidase antagonists & inhibitors
Uric Acid blood
Acute Kidney Injury drug therapy
Antineoplastic Combined Chemotherapy Protocols adverse effects
Autoantibodies immunology
Multiple Myeloma drug therapy
Urate Oxidase immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1099-1069
- Volume :
- 38
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Hematological oncology
- Publication Type :
- Report
- Accession number :
- 31985842
- Full Text :
- https://doi.org/10.1002/hon.2700